Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

06/02/2026 06:34

Feb 6 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.53               15.28            20.69    
                 (+1.7 pct)          (+2.8 pct)       (+2.8 pct)  
  Operating        559 mln             541 mln          775 mln   
                 (+3.3 pct)          (+30.6 pct)      (+9.9 pct)  
  Recurring        580 mln             553 mln          771 mln   
                 (+4.9 pct)          (+32.4 pct)      (+8.9 pct)  
  Net              289 mln             367 mln          505 mln   
                 (-21.3 pct)         (+17.7 pct)      (+9.0 pct)  
  EPS             92.94 yen          117.22 yen       162.13 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T